Login / Signup

Nomogram predicting overall survival of stage IIIB non-small-cell lung cancer patients based on the SEER database.

Ziye LiPingfan ShiChenge QinWen ZhangShumeng LinTiansheng ZhengMing LiLihong Fan
Published in: The clinical respiratory journal (2023)
We developed the first validated nomogram to estimate the OS of patients with stage IIIB NSCLC. The nomogram was based on nine prognostic factors and provided an individualized risk estimate of 3-year and 5-year OS survival in patients with stage IIIB NSCLC.
Keyphrases